ACEL (Ticker: ACEL) files Form 144 for 12,500-share planned stock sale

Rhea-AI Filing Summary

ACEL shareholders filed a Form 144 notice covering a planned sale of 12,500 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE around 12/11/2025, with an aggregate market value of $134,500. The filing notes that 83,207,946 shares were outstanding at the time of the notice, giving context to the sale’s size. In the past three months, 10b5-1 sales for Grant Place Fund LLC and Crilly Court Trust each involved 12,500 common shares, generating gross proceeds of $138,830 per seller. By signing, the seller represents they are not aware of undisclosed material adverse information about ACEL’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12500	134500.00	83207946	12/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2013	SPAC Transaction	Issuer			12500	07/01/2013	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GRANT PLACE FUND LLC 140 Tower Drive Burr Ridge IL 60527	Common	09/15/2025	12500	138830.00
10b5-1 Sales for CRILLY COURT TRUST 140 Tower Drive Burr Ridge IL 60527	Common	09/15/2025	12500	138830.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ACEL Form 144 filing disclose?

The Form 144 for ACEL discloses a planned sale of 12,500 shares of common stock, with an aggregate market value of $134,500, to be executed through Morgan Stanley Smith Barney LLC on the NYSE around 12/11/2025.

How many ACEL shares are being sold under this Form 144 and what is their value?

The notice covers 12,500 ACEL common shares with an aggregate market value of $134,500, as stated in the securities information section of the filing.

How does the planned ACEL share sale compare to total shares outstanding?

At the time of the notice, ACEL had 83,207,946 common shares outstanding, so the planned sale of 12,500 shares represents a very small portion of the total.

Which broker is handling the ACEL Form 144 share sale and on which exchange?

The sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services from New York, with trades expected to occur on the NYSE.

What recent 10b5-1 sales related to ACEL are disclosed in the Form 144?

The filing reports 10b5-1 sales on 09/15/2025 for Grant Place Fund LLC and Crilly Court Trust, each selling 12,500 ACEL common shares and receiving gross proceeds of $138,830 per transaction.

What representation does the seller make about ACEL’s information in signing Form 144?

By signing, the seller represents that they do not know any material adverse information about ACEL’s current or prospective operations that has not been publicly disclosed, consistent with the Form 144 attestation language.